Pharmacological Approach to the Treatment of Postherpetic Neuralgia

スポンサーリンク

概要

• 論文の詳細を見る

• Postherpetic neuralgia (PHN) is neuropathic pain syndrome. PHN occurred after herpes zoster which causes the peripheral nerve inflammation. PHN has been known to be relatively refractory to the standard analgesic agents, such as non-steroidal anti-inflammatory drugs and opioids. Anti-depressant drugs, anti-arrhythmic drugs and anti-convulsants are usually used for the treatment of PHN, but the results of this treatment are not always satisfactory.N-methyl-D-aspartate (NMDA) receptor dependent spinal sensitization has been shown to play an important role in the maintenance of neuropathic pain and NMDA receptor antagonists have been reported to alleviate the level of neuropathic pain in the animal model. Ketamine and dextromethorphan are the clinically available NMDA receptor antagonists and I tried to treat PHN with epidural ketamine and oral dextromethorphan. Both epidural ketamine and oral dextromethorphan successfully treated PHN. This suggested that PHN is maintained by the NMDA receptor dependent spinal sensitization.Recently, three new pharmacological approaches, such as systemic gabapentin administration, intrathecal admnistration of N-type voltage dependent Ca2+channel (VDCC) blocker and intrathecal nociceptin injection, have been tested for the treatment of neuropathic pain in the animal models. Gabapentin is a newly developed anti-convulsant drug. Oral gabapentin has already reported to treat PHN in the clinical situation. Release of neurotransmitter is regulated by the influx of Ca2+ into the nerve terminals through VDCCs, such as N-type VDCC. N-type VDCC blockers inhibit the substance P and glutamate release and intrathecal injection of N-type VDCC attenuates the level of neuropathic pain in the animal model. Nociceptin is an endogenous agonist for the opioid receptor likel receptor. Nociceptin has been reported to depress the spinal sensitization and to alleviate the level of neuropathic pain in the animal model. I believe that these three drugs will be the major approach to the treatment of PHN in near future.

• 一般社団法人 日本ペインクリニック学会の論文

一般社団法人 日本ペインクリニック学会 | 論文

• 神経障害性疼痛の症状から予測するガバペンチンの鎮痛効果
• 腰部硬膜外穿刺における各種画像検査による距離の予測
• くも膜下モルヒネに高用量のブピバカインを併用し良好な鎮痛が得られた2 症例
• 尖圭コンジローマ外科的切除時の痛み緩和目的でのリドカインテープ(ペンレス^【○!R】)使用経験
• 特発性脳脊髄液漏出症に対する経椎間孔的硬膜外自家血パッチの経験

もっと見る

スポンサーリンク